CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• Androgen receptor (AR) is crucial for prostate cancer (PC) cell proliferation.
• AR protein levels are tightly regulated by protein degradation pathways.

Purpose of the Study:

• To investigate the role of Canopy FGF signaling regulator 2 (CNPY2) in regulating AR protein levels in PC cells.
• To elucidate the mechanism by which CNPY2 affects AR stability and PC cell growth.

Main Methods:

• Investigated AR ubiquitination and degradation via the ubiquitin-proteasome pathway.
• Assessed the interaction between CNPY2, myosin regulatory light chain interacting protein (MYLIP), and UBE2D1.
• Analyzed AR target gene expression (e.g., KLK3/PSA) and PC cell growth.
• Correlated CNPY2 and AR expression in human PC tissue samples.

Main Results:

• CNPY2 was found to control AR protein levels in PC cells.
• CNPY2 inhibited MYLIP-mediated ubiquitination of AR by disrupting the MYLIP-UBE2D1 interaction.
• CNPY2 up-regulated AR target gene expression and promoted PC cell growth.
• AR overexpression rescued CNPY2 knockdown-induced growth inhibition.
• Positive correlation between CNPY2 and AR/AR target gene expression in human PC tissues.

Conclusions:

• CNPY2 promotes PC cell growth by inhibiting AR protein degradation.
• The mechanism involves CNPY2's interference with MYLIP-mediated AR ubiquitination.
• CNPY2 represents a potential therapeutic target for prostate cancer.